The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Clinical epidemiology of heart failure
Open accessAbstract
he aim of this paper is to review the clinical epidemiology of heart failure.The last paper comprehensively addressing the epidemiology of heart failure in Heart appeared in 2000.w1 Despite an increase in manuscripts describing epidemiological aspects of heart failure since the 1990s, 1 additional information is still needed, as indicated by various editorials.w2 w3The evaluation and management of heart failure is schematically depicted in fig 1.Following some methodological considerations, most issues indicated in fig 1 (risk factors, aetiology, prevalence, incidence, prognosis, prevention) will be discussed.The therapeutic management of patients diagnosed with heart failure is beyond the scope of this paper, as is detailed information about the possible diagnostic tests and strategies to establish or rule out heart failure, although the prevailing definitions and categorisations of the syndrome will be discussed.The guidelines of the European Society of Cardiology and selected reviews provide up to date information on the diagnosis and therapeutic management of heart failure. 2 w4 w5 DEFINITION AND CLASSIFICATION OF HEART FAILURE cHeart failure is a syndrome with symptoms and signs caused by cardiac dysfunction, resulting in reduced longevity.To establish a diagnosis of heart failure, the European Society of Cardiology guidelines warrant the presence of symptoms and signs (tables 1 and 2), objective evidence of cardiac dysfunction (preferably by echocardiography), and, in case of remaining doubt, a favourable response to treatment directed towards heart failure.w5 To support the failing heart numerous compensatory mechanisms occur, including activation of the neurohormonal system. 2 An increase in natriuretic peptide concentrations (particularly B type natriuretic peptide) is considered a hallmark of heart failure.The diagnosis of heart failure, especially when relying solely on symptoms and signs (which is often the case in primary care), is fraught with difficulties.3 Many patients deemed to have heart failure will simply be found to be obese, have a poor physical condition, pulmonary disease, or ischaemia on further examination.Evidence is accumulating that normal natriuretic peptide levels and a normal electrocardiogram should lead to a reconsideration of a diagnosis of heart failure.4 w6Acute versus chronic heart failure Heart failure generally is a chronic condition (chronic heart failure-CHF) in which bouts of worsening symptoms and signs can occur that may require hospitalisation or more frequent doctor visits (decompensation of CHF).Alternatively, heart failure may present acutely, with occurrence of severe symptoms and signs within 24 h.Acute heart failure clinically presents in several forms: c acute pulmonary oedema secondary to cardiac dysfunction c cardiogenic shock, usually in the setting of an acute coronary syndrome, characterised by hypotension, oliguria, and peripheral vasoconstriction c acute worsening (decompensation) of CHF.Systolic versus diastolic heart failure, impaired versus preserved left ventricular ejection fraction Heart failure traditionally was seen to result from impairment in ability of the heart to pump sufficient amounts of blood into the circulation during systole-that is, left ventricular systolic dysfunction.Echocardiography is most often employed to assess left ventricular systolic function, an ejection fraction of (40% indicating impaired left ventricular systolic function.Heart failure can also occur in patients with normal left ventricular systolic function in whom higher filling pressures are needed to obtain a normal end-diastolic volume of the left ventricle, so called heart failure with preserved left ventricular ejection fraction (PLVEF) or ''diastolic'' heart failure.w7
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
Owan, T. E., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052256 · Cited by 4,191
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093
Redfield, M. M., Jacobsen, S. J., Burnett, J. C., Mahoney, D. W., Bailey, K. R., & Rodeheffer, R. J. (2003) · JAMA · doi:10.1001/jama.289.2.194 · Cited by 3,004
The progression from hypertension to congestive heart failure
Levy, D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530440037034 · Cited by 2,155
The Seattle Heart Failure Model: Prediction of Survival in Heart Failure
Levy, W. C., Mozaffarian, D., Linker, D. T., Sutradhar, S. C., Anker, S. D., Cropp, A. B., Anand, I., Maggioni, A., Burton, P., Sullivan, M. D., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.584102 · Cited by 2,021
Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study
Lloyd-Jones, D. M., Larson, M. G., Leip, E. P., Beiser, A., D’Agostino, R. B., Kannel, W. B., Murabito, J. M., Vasan, R. S., Benjamin, E. J., & Levy, D. (2002) · Circulation · doi:10.1161/01.cir.0000039105.49749.6f · Cited by 1,613
Trends in Heart Failure Incidence and Survival in a Community-Based Population
Roger, V. L. (2004) · JAMA · doi:10.1001/jama.292.3.344 · Cited by 1,600
The epidemiology of heart failure
Cowie, M. R., Mosterd, A., Wood, D. A., Deckers, J. W., Poole-Wilson, P. A., Sutton, G. C., & Grobbee, D. E. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015223 · Cited by 1,018
Self-citationHeart failure with preserved left ventricular systolic function
Hogg, K., Swedberg, K., & McMurray, J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.07.046 · Cited by 932
Cowie, M. R., Struthers, A. D., Wood, D. A., Coats, A. J., Thompson, S. G., Poole-Wilson, P. A., & Sutton, G. C. (1997) · The Lancet · doi:10.1016/s0140-6736(97)06031-5 · Cited by 872
Cited by
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Self-citation2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Self-citationESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
Self-citation2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs105 · Cited by 2,644
Self-citationEpidemiology and risk profile of heart failure
Bui, A. L., Horwich, T. B., & Fonarow, G. C. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.165 · Cited by 2,077
“Incidence and prevalence data for HF in most countries are scarce”
Background2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
Glikson, M., Nielsen, J. C., Kronborg, M. B., Michowitz, Y., Auricchio, A., Barbash, I. M., Barrabés, J. A., Boriani, G., Braunschweig, F., Brignole, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab364 · Cited by 2,019
Groenewegen, A., Rutten, F. H., Mosterd, A., & Hoes, A. W. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1858 · Cited by 2,043
Self-citationYoung, T. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.8.893 · Cited by 1,304
Mullens, W., Damman, K., Harjola, V.-P., Mebazaa, A., Brunner-La Rocca, H.-P., Martens, P., Testani, J. M., Tang, W. H. W., Orso, F., Rossignol, P., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1369 · Cited by 1,119
Kitsiou, S., Paré, G., & Jaana, M. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.4174 · Cited by 327
“Approximately 1-2% of the adult population in the western world has HF, with the prevalence rising to ≥10% among persons 65 years of age or older [2].”
Staniute, M., Brozaitiene, J., Burkauskas, J., Kazukauskiene, N., Mickuviene, N., & Bunevicius, R. (2015) · Health and Quality of Life Outcomes · doi:10.1186/s12955-014-0204-2 · Cited by 332
Sokoreli, I., de Vries, J. J. G., Pauws, S. C., & Steyerberg, E. W. (2016) · Heart Failure Reviews · doi:10.1007/s10741-015-9517-4 · Cited by 251
Zannad, F., Garcia, A. A., Anker, S. D., Armstrong, P. W., Calvo, G., Cleland, J. G. F., Cohn, J. N., Dickstein, K., Domanski, M. J., Ekman, I., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft095 · Cited by 231
Effects of Vitamin D on Cardiac Function in Patients With Chronic HF
Witte, K. K., Byrom, R., Gierula, J., Paton, M. F., Jamil, H. A., Lowry, J. E., Gillott, R. G., Barnes, S. A., Chumun, H., Kearney, L. C., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.508 · Cited by 229
Kolkhof, P., Jaisser, F., Kim, S.-Y., Filippatos, G., Nowack, C., & Pitt, B. (2016) · Handbook of Experimental Pharmacology · doi:10.1007/164_2016_76 · Cited by 180
Heart failure epidemiology: European perspective
Guha, K., & McDonagh, T. (2013) · Current Cardiology Reviews · doi:10.2174/1573403x11309020005 · Cited by 137
Smeulders, E. S. T. F., Van Haastregt, J. C. M., Ambergen, T., Uszko‐Lencer, N. H. K. M., Janssen‐Boyne, J. J. J., Gorgels, A. P. M., Stoffers, H. E. J. H., Lodewijks‐van der Bolt, C. L. B., Van Eijk, J. T. M., & Kempen, G. I. J. M. (2010) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2010.05318.x · Cited by 110
The role of wearables in heart failure
Singhal, A., & Cowie, M. R. (2020) · Current Heart Failure Reports · doi:10.1007/s11897-020-00467-x · Cited by 85
Bibliometric analysis on the Progress of chronic heart failure
Wang, H., Shi, J., Shi, S., Bo, R., Zhang, X., & Hu, Y. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101213 · Cited by 84
Heart Failure Patients Monitored With Telemedicine: Patient Satisfaction, a Review of the Literature
Kraai, I. H., Luttik, M. L. A., de Jong, R. M., Jaarsma, T., & Hillege, H. L. (2011) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2011.03.009 · Cited by 78
Sarwar, M., Samuel, C. S., Bathgate, R. A., Stewart, D. R., & Summers, R. J. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12964 · Cited by 74
Werhahn, S. M., Dathe, H., Rottmann, T., Franke, T., Vahdat, D., Hasenfuß, G., & Seidler, T. (2019) · ESC Heart Failure · doi:10.1002/ehf2.12425 · Cited by 59
Cygankiewicz, I., Zareba, W., Vazquez, R., Bayes-Genis, A., Pascual, D., Macaya, C., Almendral, J., Fiol, M., Bardaji, A., Gonzalez-Juanatey, J. R., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.11.061 · Cited by 58
Denollet, J., Vrints, C. J., & Conraads, V. M. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.10.015 · Cited by 58
Ciere, Y., Cartwright, M., & Newman, S. P. (2012) · Journal of Telemedicine and Telecare · doi:10.1258/jtt.2012.111009 · Cited by 50
Reducing lipofuscin accumulation and cardiomyocytic senescence of aging heart by enhancing autophagy
Li, W.-W., Wang, H.-J., Tan, Y.-Z., Wang, Y.-L., Yu, S.-N., & Li, Z.-H. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112585 · Cited by 47
Gill, P. S., Calvert, M., Davis, R., Davies, M. K., Freemantle, N., & Lip, G. Y. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026710 · Cited by 43
Domingo, M., Lupón, J., González, B., Crespo, E., López, R., Ramos, A., Urrutia, A., Pera, G., Verdú, J. M., & Bayes-Genis, A. (2012) · European Journal of Cardiovascular Nursing · doi:10.1016/j.ejcnurse.2011.02.003 · Cited by 36
Yu, D. S. F., Lee, D. T. F., Thompson, D. R., Jaarsma, T., Woo, J., & Leung, E. M. F. (2011) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2010.08.011 · Cited by 34
Arrhythmogenic and metabolic remodelling of failing human heart
Gloschat, C. R., Koppel, A. C., Aras, K. K., Brennan, J. A., Holzem, K. M., & Efimov, I. R. (2016) · The Journal of Physiology · doi:10.1113/jp271992 · Cited by 23
Serum potassium and heart failure: association, causation, and clinical implications
Sfairopoulos, D., Arseniou, A., & Korantzopoulos, P. (2021) · Heart Failure Reviews · doi:10.1007/s10741-020-10039-9 · Cited by 23
Czech Society of Cardiology Guidelines for the Diagnosis and Treatment of Chronic Heart Failure 2011
Špinar, J., Vítovec, J., Hradec, J., Málek, I., Meluzín, J., Špinarová, L., Hošková, L., Hegarová, M., Ludka, O., & Táborský, M. (2012) · Cor et Vasa · doi:10.1016/j.crvasa.2012.03.002 · Cited by 10
Metadata
- Authors
- Mosterd, A., & Hoes, A. W.
- Venue
- Heart
- Publisher
- BMJ
- Published
- 2007-08-14
- Volume
- 93
- Issue
- 9
- Pages
- 1137-1146
- ISSN
- 1355-6037 (ISSN-L)
- 1468-201X
- OpenAlex
- W2167666858
- Cited by
- 1,922
- References
- 33
- FWCI
- 18.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.